Joel M. Reid

CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism

Juliana Camacho-Pereira, Mariana G. Tarragó, Claudia C.S. Chini et al. · Cell Metabolism · 2016 · 867 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +16

Phase I and Pharmacodynamic Study of the Oral MEK Inhibitor CI-1040 in Patients With Advanced Malignancies

Patricia LoRusso, Alex A. Adjei, Mary Varterasian et al. · Journal of Clinical Oncology · 2005 · 399 citations

Medicine, Oncology, Pharmacology +17

Modulating Pharmacokinetics, Tumor Uptake and Biodistribution by Engineered Nanoparticles

Rochelle R. Arvizo, Oscar R. Miranda, Daniel F. Moyano et al. · PLoS ONE · 2011 · 393 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Targeted Delivery of Gemcitabine to Pancreatic Adenocarcinoma Using Cetuximab as a Targeting Agent

Chitta Ranjan Patra, Resham Bhattacharya, Enfeng Wang et al. · Cancer Research · 2008 · 368 citations

Pharmacy, Pharmaceutics, Pharmacology +17

Phase II Trial of Vorinostat in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study

Evanthia Galanis, Kurt A. Jaeckle, Matthew J. Maurer et al. · Journal of Clinical Oncology · 2009 · 357 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17